2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$450.91+$3.63 (+0.81%)
Price as of Oct 22, 2026 7:59 PM EDT- $237.0BMarket Cap
- 52.21%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$450.91+$3.63 (+0.81%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $447.28 | ||
Change | -$0.60 (-0.14%) | ||
Open | $441.55 | ||
High | $450.98 | ||
Low | $437.19 | ||
Previous Close | $438.94 | ||
Volume | 2,610,628 | ||
30-Day Average Volume | 2,788,683 | ||
1-Week Change | 2.87% | ||
1-Month Change | 11.49% | ||
1-Year Change | 52.21% | ||
3-Year Change | 72.00% | ||
5-Year Change | 145.05% | ||
Fundamentals | |||
Shares Outstanding | 540.6M | ||
Total Assets | $95.6B | ||
Market Cap | $237.0B | ||
Enterprise Value | $280.3B | ||
Period: QTR TTM FY | |||
Revenue | $9.5B | ||
Net Income | $2.4B | ||
Free Cash Flow | $3.5B | ||
EBIT | $3.4B | ||
EBITDA | $4.6B | ||
Net Working Capital | $9.5B | ||
EPS | $4.37 | ||
Enterprise Value/EBITDA | 62 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 20 | ||
P/E | 100 | ||
PEG | 3 | ||
Price/Free Cash Flow | 68 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.30% | ||
Trailing Annual Dividend Yield | 2.27% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield